期刊
MOLECULAR BIOLOGY AND EVOLUTION
卷 39, 期 7, 页码 -出版社
OXFORD UNIV PRESS
DOI: 10.1093/molbev/msac136
关键词
cancer evolution; genomics; statistical modeling
资金
- NIH [U54CA217376, R01LM013438]
- Flinn Foundation [2088]
- ASU-Mayo Seed Grant
Understanding intratumor heterogeneity is crucial for studying tumorigenesis and designing personalized treatments. This study presents a novel algorithm, MAGOS, that successfully identifies subclones in tumors sequenced at low depths and outperforms existing methods in terms of decomposition accuracy, minimum sequencing depth, and computation efficiency. The analysis of late-stage liver cancers using MAGOS revealed that a high subclone count in a tumor is a significant risk factor for poor prognosis.
Understanding intratumor heterogeneity is critical for studying tumorigenesis and designing personalized treatments. To decompose the mixed cell population in a tumor, subclones are inferred computationally based on variant allele frequency (VAF) from bulk sequencing data. In this study, we showed that sequencing depth, mean VAF, and variance of VAF of a subclone are confounded. Without considering this effect, current methods require deep-sequencing data (>300x depth) to reliably infer subclones. Here, we present a novel algorithm that incorporates depth-variance and mean-variance dependencies in a clustering error model and successfully identifies subclones in tumors sequenced at depths of as low as 30x. We implemented the algorithm as a model-based adaptive grouping of subclones (MAGOS) method. Analyses of computer simulated data and empirical sequencing data showed that MAGOS outperformed existing methods on minimum sequencing depth, decomposition accuracy, and computation efficiency. The most prominent improvements were observed in analyzing tumors sequenced at depths between 30x and 200x, whereas the performance was comparable between MAGOS and existing methods on deeply sequenced tumors. MAGOS supports analysis of single-nucleotide variants and copy number variants from a single sample or multiple samples of a tumor. We applied MAGOS to whole-exome data of late-stage liver cancers and discovered that high subclone count in a tumor was a significant risk factor of poor prognosis. Lastly, our analysis suggested that sequencing multiple samples of the same tumor at standard depth is more cost-effective and robust for subclone characterization than deep sequencing a single sample. MAGOS is available at github (https://github.com/liliulab/magos).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据